M
Mattia Boeri
Researcher at University of Milan
Publications - 61
Citations - 3073
Mattia Boeri is an academic researcher from University of Milan. The author has contributed to research in topics: Lung cancer & Lung cancer screening. The author has an hindex of 22, co-authored 51 publications receiving 2300 citations.
Papers
More filters
Journal ArticleDOI
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
Mattia Boeri,Carla Verri,Davide Conte,Luca Roz,Piergiorgio Modena,Federica Facchinetti,Elisa Calabrò,Carlo M. Croce,Ugo Pastorino,Gabriella Sozzi +9 more
TL;DR: A role for miRNAs in lung tissues and plasma as molecular predictors of lung cancer development and aggressiveness is indicated and has theoretical and clinical implication for lung cancer management.
Journal ArticleDOI
Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
Gabriella Sozzi,Mattia Boeri,Marta Rossi,Carla Verri,Paola Suatoni,Francesca Bravi,Luca Roz,Davide Conte,Michela Grassi,Nicola Sverzellati,Alfonso Marchianò,Eva Negri,Carlo La Vecchia,Ugo Pastorino +13 more
TL;DR: This large validation study indicates that MSC has predictive, diagnostic, and prognostic value and could reduce the false-positive rate of LDCT, thus improving the efficacy of lung cancer screening.
Journal ArticleDOI
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
Ugo Pastorino,Mario Silva,Stefano Sestini,Federica Sabia,Mattia Boeri,Anna Cantarutti,Nicola Sverzellati,Gabriella Sozzi,Giovanni Corrao,Alfonso Marchianò +9 more
TL;DR: The MILD trial provides additional evidence that prolonged screening beyond 5 years can enhance the benefit of early detection and achieve a greater overall and LC mortality reduction compared with NLST trial.
Journal ArticleDOI
Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade
Giuseppe Lo Russo,Massimo Moro,Michele Sommariva,Valeria Cancila,Mattia Boeri,Giovanni Centonze,Simona Ferro,Monica Ganzinelli,Patrizia Gasparini,Veronica Huber,Massimo Milione,Luca Porcu,Claudia Proto,Giancarlo Pruneri,Diego Signorelli,Sabina Sangaletti,Lucia Sfondrini,Chiara Storti,Elena Tassi,Alberto Bardelli,Silvia Marsoni,Valter Torri,Claudio Tripodo,Mario P. Colombo,Andrea Anichini,Licia Rivoltini,Andrea Balsari,Gabriella Sozzi,Marina Chiara Garassino +28 more
TL;DR: These results suggest a crucial role of TAM reprogramming, upon Fc receptor engagement by ICI, eventually inducing HP and provide clues on a distinctive immunophenotype potentially able to predict HP.
Journal ArticleDOI
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Luis M. Seijo,Nir Peled,Daniel Ajona,Mattia Boeri,John K. Field,Gabriella Sozzi,Ruben Pio,Javier J. Zulueta,Avrum Spira,Pierre P. Massion,Peter J. Mazzone,Luis M. Montuenga +11 more
TL;DR: The present review is an update of the research and development efforts regarding the use of molecular biomarkers in the lung cancer screening setting and proposes some principles to optimize lung cancer biomarker discovery projects.